Point72 Asia Singapore Pte. Ltd. Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

Point72 Asia Singapore Pte. Ltd. bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 10,078 shares of the healthcare conglomerate’s stock, valued at approximately $5,098,000. UnitedHealth Group accounts for about 1.3% of Point72 Asia Singapore Pte. Ltd.’s investment portfolio, making the stock its 11th biggest position.

A number of other large investors have also added to or reduced their stakes in the stock. Rosenberg Matthew Hamilton boosted its holdings in shares of UnitedHealth Group by 50.3% during the 4th quarter. Rosenberg Matthew Hamilton now owns 1,320 shares of the healthcare conglomerate’s stock valued at $668,000 after acquiring an additional 442 shares in the last quarter. Tuttle Capital Management LLC raised its holdings in UnitedHealth Group by 34.1% during the 4th quarter. Tuttle Capital Management LLC now owns 629 shares of the healthcare conglomerate’s stock worth $318,000 after purchasing an additional 160 shares during the last quarter. Tlwm increased its position in shares of UnitedHealth Group by 4.0% during the fourth quarter. Tlwm now owns 2,708 shares of the healthcare conglomerate’s stock worth $1,370,000 after buying an additional 105 shares during the period. Lpwm LLC lifted its stake in shares of UnitedHealth Group by 80.8% in the 4th quarter. Lpwm LLC now owns 866 shares of the healthcare conglomerate’s stock valued at $438,000 after purchasing an additional 387 shares during the period. Finally, SeaCrest Wealth Management LLC grew its position in shares of UnitedHealth Group by 2.3% during the 4th quarter. SeaCrest Wealth Management LLC now owns 3,223 shares of the healthcare conglomerate’s stock worth $1,630,000 after buying an additional 71 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on UNH. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft cut their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a report on Wednesday. Morgan Stanley cut their price objective on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research report on Wednesday. Barclays lowered their price objective on shares of UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating on the stock in a research report on Monday, April 21st. Finally, Oppenheimer dropped their price target on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a research report on Wednesday. Six equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $523.52.

UnitedHealth Group Stock Down 1.0%

Shares of UnitedHealth Group stock opened at $308.35 on Thursday. The firm has a market cap of $279.72 billion, a price-to-earnings ratio of 19.89, a PEG ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $284.25 and a 1 year high of $630.73. The company has a 50-day moving average of $478.83 and a 200 day moving average of $517.83.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period last year, the firm posted $6.91 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.72%. UnitedHealth Group’s payout ratio is currently 35.18%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.